These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25378667)

  • 21. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-dimensional-ratio measures of atrophy progression in multiple sclerosis as evaluated by longitudinal magnetic resonance imaging.
    Martola J; Stawiarz L; Fredrikson S; Hillert J; Bergström J; Flodmark O; Aspelin P; Wiberg MK
    Acta Radiol; 2009 Oct; 50(8):924-32. PubMed ID: 19639474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
    Dolezal O; Gabelic T; Horakova D; Bergsland N; Dwyer MG; Seidl Z; Krasensky J; Ramasamy DP; Vaneckova M; Havrdova E; Zivadinov R
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S42-8. PubMed ID: 24321154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
    De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
    Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging.
    Miki Y; Grossman RI; Udupa JK; van Buchem MA; Wei L; Phillips MD; Patel U; McGowan JC; Kolson DL
    Radiology; 1999 Mar; 210(3):769-74. PubMed ID: 10207480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
    Foster M; Zivadinov R; Weinstock-Guttman B; Tamaño-Blanco M; Badgett D; Carl E; Ramanathan M
    J Neuroimmunol; 2012 Feb; 243(1-2):61-8. PubMed ID: 22261546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
    Uher T; Vaneckova M; Krasensky J; Sobisek L; Tyblova M; Volna J; Seidl Z; Bergsland N; Dwyer MG; Zivadinov R; De Stefano N; Sormani MP; Havrdova EK; Horakova D
    Mult Scler; 2019 Apr; 25(4):541-553. PubMed ID: 29143562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
    Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
    Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain volume and fatigue in patients with postpoliomyelitis syndrome.
    Trojan DA; Narayanan S; Francis SJ; Caramanos Z; Robinson A; Cardoso M; Arnold DL
    PM R; 2014 Mar; 6(3):215-20. PubMed ID: 24060387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
    Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
    Sbardella E; Tomassini V; Stromillo ML; Filippini N; Battaglini M; Ruggieri S; Ausili Cefaro L; Raz E; Gasperini C; Sormani MP; Pantano P; Pozzilli C; De Stefano N
    Mult Scler; 2011 Dec; 17(12):1432-40. PubMed ID: 21729978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI in the diagnosis of pediatric multiple sclerosis.
    Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
    Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.
    Donohue K; Cox JL; Dwyer MG; Aliotta R; Corwin M; Weinstock-Guttman B; Ann Yeh E; Zivadinov R
    J Neuroimaging; 2014; 24(1):63-7. PubMed ID: 23317029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal thinning of the cerebral cortex in multiple sclerosis.
    Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
    Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.